抗发作药物在患者群体中的精神病学影响
Bushra Khalid1, Zaid Waqar2, Soban Khan1
1Pakistan Institute of Medical sciences, Islamabad, Pakistan.
BMC neurology
|May 21, 2024
概括
服用多种抗发作药物的患者或控制不良的患者面临更高的精神病并发症风险. 这凸显了优化治疗对更好的心理健康结果的重要性.
科学领域:
- 神经学 神经学
- 精神病学是一个精神病学.
- 临床医学 临床医学
背景情况:
- 是一种常见的神经系统疾病,常见的精神病并发症影响生活质量.
- 了解治疗与心理健康之间的联系对于患者护理至关重要.
研究的目的:
- 调查抗发作疗法与患者精神病并发症之间的关联.
- 为了确定可能增加心理健康问题的风险的特定治疗因素.
主要方法:
- 一项涉及120名来自巴基斯坦伊斯兰堡神经病学推中心的患者的研究.
- 通过关于管理,抗药物和精神病相关疾病的标准化问卷收集的数据.
- 使用SPSS进行统计分析以评估关联.
主要成果:
- 使用多种抗发作药物 (多疗法) 的患者与单疗法患者相比,精神病并发症的可能性显著更高 (p=0.010).
- 控制不良的人比控制良好的人更容易患上精神病并发症 (p=0.029).
结论:
- 多疗法和不充分的控制与中精神病并发症风险增加有关.
- 优化抗发作治疗和控制发作可能对减轻患者的心理健康风险至关重要.
更多相关视频
相关概念视频
Antiepileptic Drugs: Sodium Channel Blockers
511
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
511
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
286
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
286
Antiepileptic Drugs: Calcium Channel Blockers
373
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
373
Antiepileptic Drugs: Glutamate Antagonists
320
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
320
Antiepileptic Drugs: GABAergic Pathway Potentiators
385
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
385
Antiepileptic Drugs: Potassium Channel Activators
173
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
173


